Orthopedic Biomaterials Market Research Report- Forecast till 2027

Orthopedic Biomaterial Market: Information by Product (Reconstructive Joint Replacement, SpinalImplants, Dental Implants,Trauma, Orthobiologics), Material Class (Metal andNon-Metal), Application (Joint Replacement, Fracture Fixation, Tissue Fixation, Implant Surgery,Visco Supplementation), End User (Hospitals & Clinics, Ambulatory Surgical Centers), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/0101-CR | August 2021 | Region: Global | 240 pages

Orthopedic Biomaterial Market Forecast


The orthopedic biomaterials market is expected to register a CAGR of 10. 5% during the assessment period of 2020 to 2027, to reach USD 40,519.52 million by 2027.


Market Overview:


Orthopedic biomaterials are implanted in the human body as constituents. These devices are designed to perform certain biological functions by substituting or repairing different tissues such as bone, cartilage, or ligaments and tendons and even guiding bone repair when necessary.


The growth of the orthopedic biomaterials market is driven by factors such as the growing demand for next-generation orthopedic biomaterials and the increasing prevalence of orthopedic diseases. In addition, the increasing prevalence of chronic diseases creates a lucrative opportunity for the market. However, lack of reimbursement and an ambiguous regulatory framework is likely to restrain the market growth.


COVID-19 Analysis:


The pandemic is likely to have devastating effects on the global economy, more intense than the global financial crisis during 2008-2009. It is affecting the demand and supply chain, which will severely hurt global trade. The top players in the market are expected to continue to fulfill the current demand for orthopedic biomaterials, including reconstructive joint replacements and spinal implants. Furthermore, various governments across the world are encouraging the key players to improve the current manufacturing facilities. However, with the decline in elective surgical procedures, the orthopedic biomaterials market is expected to witness a slump in 2020.


Market Dynamics:


Drivers


  • Increasing older population leading to an increase in the patient population


Geriatric individuals are more susceptible to orthopedic diseases. Thus, the growing geriatric population is likely to increase the demand for orthopedic biomaterials. According to the Office for National Statistics, in 2017, ~18% and 2.4% of the total UK population was aged over 65 years and 85 years, respectively. With the high incidence of joint replacement procedures, over 1 million hip and total knee replacement procedures are performed each year in the US. This huge number of joint and knee replacements is increasing the demand for orthopedic biomaterial. Therefore, the growing elderly population is anticipated to boost the growth of the global orthopedic biomaterials market over the assessment period.

Growing demand for next-generation orthopedic biomaterials


Restraints


  • Lack of reimbursements


Limited reimbursement coverage options are present for these products. The reimbursement for orthopedic biomaterials is also declining in various countries, which has impeded market growth. This lack of reimbursements has put pressure on manufacturers to lower the prices for these materials. All these factors have restricted the growth of the market.


Opportunities


  • Technological advancement in the medical implants market


Nowadays, consumers are becoming more conscious and aware of the issues related to health. Thus, companies are focusing more on research & development to introduce better technology and treatment, which gives them an edge over their competitors. Companies are looking forward to introducing innovative technologies. Currently, several devices are present in the market for various medical conditions. Players focus on the development of technologically advanced products. For instance, in September 2019, Zimmer Biomet Holdings, Inc., a US-based healthcare solutions provider, announced FDA 510(k) clearance for the Persona Revision Knee System for revision knee replacement procedures. It offers components designed to match a patient's anatomy for a personalized fit.


Orthopedic Biomaterials Market Share (%), by Product, 2019
Global Orthopedic Biomaterials Market Share (%), by Product, 2019
Source: MRFR Analysis


Value Chain Analysis


The global orthopedic biomaterials market is growing steadily due to the rising incidence of orthopedic injury and growing demand for next-generation orthopedic biomaterial. So,with the rising use of orthopedic biomaterial, many players are showing keen interest in launching new products. The value chain analysis of the orthopedic biomaterials market comprises four major components: the software development process and designing, followed by R&D and designing, manufacturing, distribution, marketing,and sales with post-selling services.


Segment Overview:


By Product



  • Reconstructive Joint Replacements:


Reconstructive joint replacement is a medical procedure that includes the replacement of the damaged joint. It includes minor repair to total joint replacement, and offers pain relief as well as permanent solutions to joint disorders. Reconstructive joint replacements include various types of implants, such as knee replacement implants, hip replacement implants, and others. According to the American Academy of Orthopedic Surgeons (AAOS), around 1.6 million hip and knee surgeries and 966,000 knee replacements were performed in the US in 2017.


The market growth of this segment is attributed to the increasing geriatric population and rising cases of orthopedic surgery. Moreover, there has been a strong focus on improving healthcare services globally, which further boosts the market's growth.



  • Spinal Implants:


A spinal implant is a type of medical device used in the management of spine disorders. Spinal implants consist of polyetheretherketone (PEEK) and titanium alloys. Cobalt chromium alloys are used in disc replacements type of spinal implants. As per the North American Spine Society, around 1.4 million spinal procedures were performed each year in the US. The largest number of procedures were performed in cervical repair, with over 350,000 total procedures.



  • Dental Implants:


Dental implants are a type of surgical component that edges with the jaw's bone to support dental prostheses like crowns, dentures, and facial prostheses. Moreover, the modern dental implant is a biological process also known as osseointegration, in which titanium material is used to form a close bond to the bone. Dental implants have two types such as root-form dental implants and plate-form dental implants.



  • Trauma:


Trauma is a critical injury to the bones, joints, ligaments, muscles, and soft tissue caused by accident and fall. As per the World Health Organization, prevalence of trauma orthopedic injury is around 63.6%.



  • Orthobiologics:


Orthobiologics are biological substances used to provide relief in musculoskeletal injuries.Orthobiologics are various types such as viscosupplementation, demineralized bone matrix, synthetic bone substitutes, bone morphogenetic proteins, and allograft.



  • Others:


This segment includes orthopedic biomaterials such as bio-resorbable tissue fixation, and osteosynthesis among others.


By Material Class



  • Metal


In load-bearing systems such as hip and knee prostheses and to fix internal and external bone fractures, metallic biomaterials haveprincipal applications. It is important to know the physical and chemical properties and interaction with the human body's host tissue of the various metallic materials used in orthopedic surgery.


  • Non-Metal


With the magnum PI's polyetheretherketone (PEEK) implant material systems, surgeons who choose not to use metal anchors may incorporate alternatives. The system can be seen in several shoulder-related surgical operations and Achilles tendon replacements, among many other indications. Together with cortical bone lock, knotless fixation, and a simple technique, an implant makes the procedure quick, effective, and secure. The implant is put in an easy-to-use implanted handle.


By Application



  • Joint Replacement


The joint replacement procedure eliminates and replaces damaged or diseased joint parts with new and artificial parts. The growth during the forecast period in the knee segment has been led by a rise in the number of knee replacement procedures, robotic-assisted replacement procedures, and the introduction of products such as the ATTUNE Revision Knee System, the Persona Partial Knee System, and JOURNEY II XR Total Knee by key manufacturers.


  • Fracture Fixation


The rising geriatric population, rapid adoption of new technologies, rising prevalence of osteoporosis, and increasing injuries are the main factors for the growth of the orthopedic fracture fixation segment. Changes in the lifestyle, such as lack of exercise, early burnout, and increased obesity amongst people are resulting in the weakening of bone fractures, which drive the growth of theorthopedicbiomaterials market.



  • Tissue Fixation


Sportspersons recovering from athletic injuries isa significant factor supporting the market growth of soft tissue fixation. The incidence of sports accidents, which is projected to fuel the market growth, will also increase with a growing number of children and teenagers taking part in sports activities.



  • Implant Surgery


Orthopedic implants are used to repair or sustain a broken or deformed bone or joint. These implants are designed to cure posture issues, regain natural skeletal functions, and remove deformities. An orthopedic implant is to replace older prosthetics. The demand for orthopedic implant products has increased due to a rise in the geriatric population, raising the risk of osteoporosis, osteoarthritis, and other musculoskeletal disorders.



  • Viscosupplementation


Viscosupplementation is a minimally invasive technique in which an injection of hyaluronic acid (an active compound in synovial fluid) is commonly used. The bulk of the orthopedic operations are performed in the leg. There are 1 to 3 injection procedures with 3-injection treatments showing better pain relief than a 1-injection regimen.


By End User



  • Hospitals & Clinics


There has been a significant increase in the number of hospital admissions and patient visits for orthopedic surgeries in the majority of the countries. In 2017, the number of orthopedic surgery procedures performed globally totaled around 22.3 million. The hospitals & clinics segment dominated the global orthopedicbiomaterials market in 2019 in terms of revenue.



  • Ambulatory Surgical Centers


Ambulatory Surgery Centersor ASCs, are modern healthcare facilities where surgeries do not require hospital admission and provide same-day surgical care, including diagnostic and preventive procedures. The orthopedic biomaterial provided by ASCs is anticipated to increase the number of patients opting for orthopedic injury during the forecast period.



  • Others


The others segment includes research& academics, nursing homes, etc. The growth of the segment is attributed to the growing use of orthopedic biomaterial in various orthopedic diseases.


Orthopedic Biomaterials Market Share, by Region, 2019 (%)
Global Orthopedic Biomaterials Market Share, by Region, 2019 (%)
Source: MRFR Analysis


Regional Analysis


Americas:


The Americas dominated the orthopedicbiomaterials market in 2019 and is likely to continue during the assessment period as well. This can be attributed to the high prevalence of orthopedic diseases, product launches, and technological advancement in this region. The high demand for orthopedic biomaterials and the adequate availability of skilled professionals in the region are expected to fuel the regional market growth. The growing elderly population is also resulting in the growth of the orthopedicbiomaterials market in the Americas. As per the Administration for Community Living, in the Americas, over the last ten years, the population aged 65 and over grew from 37.2 million in 2006 to 49.2 million in 2016.


Europe:


Europe held the second-largest position in the orthopedic biomaterials market in 2019 and is anticipated to witness significant growth over the forecast period due to a higher number of patients and the availability of products in the region. In 2017, Switzerland, Finland, Luxembourg, Germany, Austria, and Belgium were among the countries with the highest number of hip and knee replacements in the region. The OECD averages are 182 per 100,000 population for hip replacements and 135 per 100,000 for knee replacements. On average, hip replacement rates increased by 30% between 2007 and 2017, and knee replacement rates increased by 40% in the same period. This increase in patients undergoing knee and replacement is anticipated to boost the regional market's growth.


Asia-Pacific:


The Asia-Pacific is anticipated to register the highest growth rate duringthe forecast period. According to the United Nations, across Asia, the number of people aged 65 and above is expected to grow dramatically over the next 50 years. For the region, the population in this age group will increase by 31.4%, from 207 million in 2000 to 857 million in 2050. A large number of adults residing in the region are expected to suffer from various orthopedic disorders. This is expected to drive the growth of the regional orthopedicbiomaterials market during the study period.


Middle East & Africa:


The orthopedic biomaterials market in the Middle East & Africa has been growing steadily in recent years. The key factors propelling the growth of the regional market are the increasing the prevalence of orthopedics disorders and funding by private players and government bodies.


Competitive Landscape


The global orthopedic biomaterials market is characterized by the presence of many global, regional, and local vendors catering to the demand created by a large patient pool in need of diagnostic and surgical services. The availability of innovative products is increasing the lucrativeness of the global orthopedic biomaterials market. The key players have adopted the strategy of signing contracts and agreements to expand their global presence and optimize operational costs.


The market is highly competitive, with players competing and partnering to gain a substantial market share. The global orthopedic biomaterials market is moderately consolidated with rising competition, product launches, rising collaborative partnerships, and other strategic decisions to achieve operational efficiency. The vendors compete based on cost, quality, timely availability, and reliability of products offered. It is decisive for the players operating in the orthopedic biomaterials market to provide cost-efficient products to survive and succeed in an increasingly competitive and growing market environment.


List of Key Companies Covered in this Report:



  1. Stryker (US)

  2. CoorsTek Inc. (US)

  3. Zimmer Biomet Holdings Inc. (US)

  4. Institut Straumann AG (Switzerland)

  5. Kyocera Corporation (Japan)

  6. Smith & Nephew plc (UK)

  7. 3M (US)

  8. Nobel Biocare Services AG(Switzerland)

  9. Medtronicplc (Ireland)

  10. DePuy Synthes (US)


Recent Developments



  • In September 2020, Smith&Nephew (UK) received approval from the National Medical Products Administration (NMPA), China, to introduce its REDAPT System for Revision Total Hip Arthroplasty (RTHA).

  • In March 2020, DePuy Synthes (US) received the European CE mark for its new BI-MENTUM Dual Mobility System for use in patients with a higher risk of dislocation. The system is designed to reduce the risk of dislocation

  • In January 2020, Nobel Biocare (Switzerland)unveiled Nexus Universal, a universal adhesive resin cement that allows medical personnel to cut their steps by half while delivering up to 2 times higher bond strength on any substrate


Report Overview:


The report contains:



  • Global orthopedic biomaterials market size and estimation from past years to forecast period (2017-2027).

  • The major market segments and their share, globally as well as regionally.

  • The market drivers, restraints, and opportunities.

  • Competitive landscape of the global orthopedic biomaterial market

  • Key market players profiling along with SWOT analysis


Scope of the Report & Segmentation


Orthopedic Biomaterials Market, by Product



  • Reconstructive Joint Replacements

    • Knee Replacement Implants

    • Hip Replacement Implants

    • Extremities



  • Spinal Implants

    • Spinal Fusion Implants

    • Vertebral Compression Fracture (VCF) Devices

    • Motion Preservation Devices/Non-Fusion Devices  



  • Dental Implants

    • Root-Form Dental Implants

    • Plate-Form Dental Implants



  • Trauma

  • Orthobiologics

    • Viscosupplementation

    • Demineralized Bone Matrix (DBM)

    • Synthetic Bone Substitutes

    • Bone Morphogenetic Protein (BMP)

    • Allograft

    • Others



  • Others


Orthopedic Biomaterials Market, by Material Class



  • Metal

    • Stainless Steel

    • Titanium Alloy

    • Cobalt Alloy

    • Others



  • Non-Metal

    • Ceramic

      • Alumina

      • Calcium Phosphate

      • Zirconium Dioxide

      • Carbon

      • Others



    • Polymeric

      • Polymethylmethacrylate (PMMA)

      • Polyethylene

      • Silicone

      • Polyester

      • Others






Orthopedic Biomaterials Market, by Application



  • Joint Replacement

    • Hip Replacement

    • Knee Replacement

    • Shoulder and Elbow Replacement

    • Others



  • Fracture Fixation

  • Tissue Fixation

  • Implant Surgery

  • Viscosupplementation

  • Other


Orthopedic Biomaterials Market, by End User



  • Hospitals & Clinics

  • Ambulatory Surgical Centers

  • Others


Global Orthopedic Biomaterials Market, by Region



  • Americas

    • North America

      • US

      • Canada

      • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • UK

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa





Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 40,519.52 Million
  CAGR   10.5% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2017-2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Material Class,Application, and End Use
  Geographies Covered   Americas, Europe, Asia-Pacific, Middle East & Africa
  Key Vendors   Stryker (US), CoorsTek Inc (US), Zimmer Biomet Holdings Inc (US), Institut Straumann AG (Switzerland), Kyocera Corporation (Japan), Smith& Nephew plc (UK),3M (US), NobelBiocare Services AG(Switzerland), Medtronic plc (Ireland), DePuy Synthes (US).
  Key Market Opportunities   Technological advancement in the medical implant market, Adoption of growth strategies by key players.
  Key Market Drivers   Growing demand for next-generation orthopedic biomaterials, increasing older population leading to increase in patient population, rising prevalence of orthopedic diseases.


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


Orthopedic Biomaterial Market is expected to grow at 10.5% CAGR By 2027.

The large geriatric populace and the massive demand for implants are major drivers of the Orthopedic Biomaterial Market.

The Americas can dominate the Orthopedic Biomaterial Market due to large demand for implants and the huge number of surgical procedures.

The APAC can grow at a robust rate due to prevalence of various chronic diseases and the large elderly populace in Chin

DePuy Synthes, Kyocera Corporation, Stryker, 3M ESPE, Materion Corporation, CERADYNE, Straumann, CoorsTek Inc., Nobel Biocare Services AG, and Morgan Advanced Materials are prominent players of the global orthopedic biomaterial market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 22

1.1 OVERVIEW 22

1.1.1 MARKET SYNOPSIS 22

2 MARKET INTRODUCTION 23

2.1 SCOPE OF THE STUDY 23

2.2 RESEARCH OBJECTIVE 23

2.3 LIST OF ASSUMPTIONS & LIMITATIONS 23

3 RESEARCH METHODOLOGY 25

3.1 OVERVIEW 25

3.2 DATA MINING 25

3.3 SECONDARY RESEARCH 26

3.4 PRIMARY RESEARCH 27

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 27

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 28

3.5 FORECASTING TECHNIQUES 29

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 30

3.6.1 BOTTOM-UP APPROACH 31

3.6.2 TOP-DOWN APPROACH 31

3.7 DATA TRIANGULATION 32

3.8 VALIDATION 32

4 MARKET DYNAMICS 33

4.1 OVERVIEW 33

4.2 DRIVERS 34

4.2.1 GROWING DEMAND FOR NEXT-GENERATION ORTHOPEDIC BIOMATERIALS 34

4.2.2 INCREASING OLDER POPULATION LEADING TO INCREASE IN THE PATIENT POPULATION 34

4.2.3 RISING PREVALENCE OF ORTHOPEDIC DISEASES 34

4.3 RESTRAINT 35

4.3.1 LACK OF REIMBURSEMENTS 35

4.3.2 AMBIGUOUS REGULATORY FRAMEWORK 35

4.4 OPPORTUNITY 36

4.4.1 TECHNOLOGICAL ADVANCEMENTS IN THE MEDICAL IMPLANTS MARKET 36

4.4.2 ADOPTION OF GROWTH STRATEGIES BY KEY PLAYERS 36


5 MARKET FACTOR ANALYSIS 37

5.1 VALUE CHAIN ANALYSIS 37

5.1.1 R&D AND DESIGNING 38

5.1.2 MANUFACTURING 38

5.1.3 DISTRIBUTION 38

5.1.4 MARKETING AND SALES 38

5.2 PORTER’S FIVE FORCES MODEL 39

5.2.1 THREAT OF NEW ENTRANTS 40

5.2.2 BARGAINING POWER OF SUPPLIERS 40

5.2.3 THREAT OF SUBSTITUTES 40

5.2.4 BARGAINING POWER OF BUYERS 40

5.2.5 INTENSITY OFRIVALRY 40

5.3 COVID-19 IMPACT ANALYSIS 41

5.3.1 IMPACT ON R&D 41

5.3.2 IMPACT ON SUPPLY CHAIN 41

5.3.3 IMPACT ON MANUFACTURERS 41

6 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT 42

6.1 OVERVIEW 42

6.2 RECONSTRUCTIVE JOINT REPLACEMENTS 44

6.2.1 KNEE REPLACEMENT IMPLANTS 45

6.2.2 HIP REPLACEMENT IMPLANTS 46

6.2.3 EXTREMITIES 46

6.3 SPINAL IMPLANTS 47

6.3.1 SPINAL FUSION IMPLANTS 48

6.3.2 VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES 49

6.3.3 MOTION PRESERVATION DEVICES/NON-FUSION DEVICES 49

6.4 DENTAL IMPLANTS 50

6.4.1 ROOT FORM DENTAL IMPLANTS 51

6.4.2 PLATE FORM DENTAL IMPLANTS 51

6.5 TRAUMA 52

6.6 ORTHOBIOLOGICS 52

6.6.1 VISCOSUPPLEMENTATION 54

6.6.2 DEMINERALIZED BONE MATRIX (DBM) 54

6.6.3 SYNTHETIC BONE SUBSTITUTES 55

6.6.4 BONE MORPHOGENETIC PROTEIN (BMP) 55

6.6.5 ALLOGRAFT 56


7 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS 57

7.1 OVERVIEW 57

7.2 METAL 58

7.2.1 STAINLESS STEEL 59

7.2.2 TITANIUM ALLOY 59

7.2.3 COBALT ALLOY 60

7.3 NON-METAL 60

7.3.1 CERAMIC 61

7.3.1.1 ALUMINA 62

7.3.1.2 CALCIUM PHOSPHATE 62

7.3.1.3 ZIRCONIUM DIOXIDE 63

7.3.1.4 CARBON 63

7.3.2 POLYMERIC 63

7.3.2.1 POLYMETHYLMETHACRYLATE (PMMA) 64

7.3.2.2 POLYETHYLENE 65

7.3.2.3 SILICONE 65

7.3.2.4 POLYESTER 65

8 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION 66

8.1 OVERVIEW 66

8.2 JOINT REPLACEMENT 67

8.2.1 HIP REPLACEMENT 68

8.2.2 KNEE REPLACEMENT 68

8.2.3 SHOULDER AND ELBOW REPLACEMENT 69

8.3 FRACTURE FIXATION 69

8.4 TISSUE FIXATION 70

8.5 IMPLANT SURGERY 70

8.6 VISCOSUPPLEMENTATION 71

8.7 OTHERS 71

9 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY END USER 72

9.1 OVERVIEW 72

9.2 HOSPITALS & CLINICS 73

9.3 AMBULATORY SURGICAL CENTERS 73

10 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY REGION 74

10.1 OVERVIEW 74

10.2 AMERICAS 76

10.2.1 NORTH AMERICA 81

10.2.1.1 US 87

10.2.1.2 CANADA 91

10.2.2 LATIN AMERICA 96

10.3 EUROPE 101

10.3.1 WESTERN EUROPE 106

10.3.1.1 GERMANY 112

10.3.1.2 FRANCE 117

10.3.1.3 UK 122

10.3.1.4 ITALY 126

10.3.1.5 SPAIN 131

10.3.1.6 REST OF WESTERN EUROPE 136

10.3.2 EASTERN EUROPE 141

10.4 ASIA-PACIFIC 146

10.4.1 CHINA 152

10.4.2 JAPAN 157

10.4.3 INDIA 162

10.4.4 AUSTRALIA 167

10.4.5 SOUTH KOREA 172

10.4.6 REST OF ASIA-PACIFIC 177

10.5 MIDDLE EAST & AFRICA 182

10.5.1 MIDDLE EAST 187

10.5.2 AFRICA 192

11 COMPETITIVE LANDSCAPE 197

11.1 OVERVIEW 197

11.2 COMPETITIVE BENCHMARKING 198

11.3 COMPETITOR DASHBOARD 199

11.4 MAJOR GROWTH STRATEGY IN THE GLOBAL ORTHOPEDIC BIOMATERIALS MARKET 199

11.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ORTHOPEDIC BIOMATERIALS MARKET 200

11.6 KEY DEVELOPMENT ANALYSIS 200

11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 201

11.7.1 PRODUCT LAUNCHES/PRODUCT APPROVALS 201

11.7.2 ACQUISITIONS 202

11.7.3 COLLABORATIONS/JOINT VENTURES 203

11.7.4 EXPANSIONS 203


12 COMPANY PROFILES 204

12.1 STRYKER 204

12.1.1 COMPANY OVERVIEW 204

12.1.2 FINANCIAL OVERVIEW 205

12.1.3 PRODUCTS/SERVICES OFFERED 205

12.1.4 KEY DEVELOPMENTS 206

12.1.5 SWOT ANALYSIS 207

12.1.6 KEY STRATEGIES 207

12.2 COORSTEK INC. 208

12.2.1 COMPANY OVERVIEW 208

12.2.2 FINANCIAL OVERVIEW 208

12.2.3 PRODUCTS/SERVICES OFFERED 208

12.2.4 KEY DEVELOPMENTS 209

12.2.5 SWOT ANALYSIS 209

12.2.6 KEY STRATEGIES 209

12.3 ZIMMER BIOMET HOLDINGS INC. 210

12.3.1 COMPANY OVERVIEWS 210

12.3.2 FINANCIAL OVERVIEW 210

12.3.3 PRODUCTS/SERVICES OFFERED 211

12.3.4 KEY DEVELOPMENTS 212

12.3.5 SWOT ANALYSIS 213

12.3.6 KEY STRATEGIES 213

12.4 INSTITUT STRAUMANN AG 214

12.4.1 COMPANY OVERVIEW 214

12.4.2 FINANCIAL OVERVIEW 214

12.4.3 PRODUCTS/SERVICES OFFERED 215

12.4.4 KEY DEVELOPMENTS 215

12.4.5 SWOT ANALYSIS 216

12.4.6 KEY STRATEGIES 216

12.5 KYOCERA CORPORATION 217

12.5.1 COMPANY OVERVIEWS 217

12.5.2 FINANCIAL OVERVIEW 217

12.5.3 PRODUCTS/SERVICES OFFERED 218

12.5.4 KEY DEVELOPMENTS 218

12.5.5 SWOT ANALYSIS 218

12.5.6 KEY STRATEGIES 219

12.6 SMITH& NEPHEW 220

12.6.1 COMPANY OVERVIEW 220

12.6.2 FINANCIAL OVERVIEW 220

12.6.3 PRODUCTS/SERVICES OFFERED 221

12.6.4 KEY DEVELOPMENTS 221

12.6.5 SWOT ANALYSIS 222

12.6.6 KEY STRATEGIES 222

12.7 3M 223

12.7.1 COMPANY OVERVIEW 223

12.7.2 FINANCIAL OVERVIEW 224

12.7.3 PRODUCTS/SERVICES OFFERED 225

12.7.4 KEY DEVELOPMENTS 225

12.7.5 SWOT ANALYSIS 226

12.7.6 KEY STRATEGIES 226

12.8 NOBEL BIOCARE HOLDING AG 227

12.8.1 COMPANY OVERVIEW 227

12.8.2 FINANCIAL OVERVIEW 228

12.8.3 PRODUCTS/SERVICES OFFERED 229

12.8.4 KEY DEVELOPMENTS 229

12.8.5 SWOT ANALYSIS 230

12.8.6 KEY STRATEGIES 230

12.9 MEDTRONIC PLC 231

12.9.1 COMPANY OVERVIEW 231

12.9.2 FINANCIAL OVERVIEW 231

12.9.3 PRODUCTS/SERVICES OFFERED 232

12.9.4 KEY DEVELOPMENTS 232

12.9.5 SWOT ANALYSIS 233

12.9.6 KEY STRATEGIES 233

12.10 DEPUY SYNTHES 234

12.10.1 COMPANY OVERVIEW 234

12.10.2 FINANCIAL OVERVIEW 235

12.10.3 PRODUCTS/SERVICES OFFERED 236

12.10.4 KEY DEVELOPMENTS 236

12.10.5 SWOT ANALYSIS 237

12.10.6 KEY STRATEGIES 237

13 APPENDIX 238

13.1 REFERENCES 238

13.2 RELATED REPORTS 238


LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 23

TABLE 2 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 43

TABLE 3 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS,BY REGION,

2017–2027 (USD MILLION) 44

TABLE 4 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 45

TABLE 5 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR KNEE REPLACEMENT IMPLANTS, BY REGION,2017–2027 (USD MILLION) 45

TABLE 6 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR HIP REPLACEMENT IMPLANTS, BY REGION,2017–2027 (USD MILLION) 46

TABLE 7 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR EXTREMITIES, BY REGION, 2017–2027(USD MILLION) 46

TABLE 8 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY REGION,2017–2027 (USD MILLION) 47

TABLE 9 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 48

TABLE 10 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL FUSION IMPLANTS, BY REGION, 2017–2027 (USD MILLION) 48

TABLE 11 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES, BY REGION,

2017–2027 (USD MILLION) 49

TABLE 12 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR MOTION PRESERVATION DEVICES/NON-FUSION DEVICES, BY REGION,

2017–2027 (USD MILLION) 49

TABLE 13 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY REGION, 2017–2027(USD MILLION) 50

TABLE 14 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 51

TABLE 15 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR ROOT FORM DENTAL IMPLANTS, BY REGION,2017–2027 (USD MILLION) 51

TABLE 16 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR PLATE FORM DENTAL IMPLANTS, BY REGION,2017–2027 (USD MILLION) 51

TABLE 17 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR TRAUMA, BY REGION, 2017–2027 (USD MILLION) 52

TABLE 18 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY REGION, 2017–2027(USD MILLION) 52

TABLE 19 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 53

TABLE 20 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR VISCOSUPPLEMENTATION, BY REGION, 2017–2027 (USD MILLION) 54

TABLE 21 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR DEMINERALIZED BONE MATRIX (DBM), BY REGION,

2017–2027 (USD MILLION) 54

TABLE 22 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR SYNTHETIC BONE SUBSTITUTES, BY REGION,2017–2027 (USD MILLION) 55

TABLE 23 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR BONE MORPHOGENETIC PROTEIN (BMP),BY REGION,

2017–2027 (USD MILLION) 55

TABLE 24 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR ALLOGRAFT, BY REGION, 2017–2027 (USD MILLION) 56

TABLE 25 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 57

TABLE 26 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY REGION, 2017–2027 (USD MILLION) 58

TABLE 27 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 59

TABLE 28 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR STAINLESS STEEL, BY REGION, 2017–2027(USD MILLION) 59

TABLE 29 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR TITANIUM ALLOY, BY REGION, 2017–2027(USD MILLION) 59

TABLE 30 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR COBALT ALLOY, BY REGION, 2017–2027(USD MILLION) 60

TABLE 31 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY REGION, 2017–2027 (USD MILLION) 60

TABLE 32 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 61

TABLE 33 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY REGION, 2017–2027 (USD MILLION) 61

TABLE 34 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 62

TABLE 35 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR ALUMINA, BY REGION, 2017–2027 (USD MILLION) 62

TABLE 36 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR CALCIUM PHOSPHATE, BY REGION, 2017–2027(USD MILLION) 62

TABLE 37 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR ZIRCONIUM DIOXIDE, BY REGION, 2017–2027(USD MILLION) 63

TABLE 38 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR CARBON, BY REGION, 2017–2027 (USD MILLION) 63

TABLE 39 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY REGION, 2017–2027 (USD MILLION) 63

TABLE 40 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 64

TABLE 41 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMETHYLMETHACRYLATE (PMMA), BY REGION,

2017–2027 (USD MILLION) 64

TABLE 42 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR POLYETHYLENE, BY REGION, 2017–2027(USD MILLION) 65

TABLE 43 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR SILICONE, BY REGION, 2017–2027 (USD MILLION) 65

TABLE 44 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR POLYESTER, BY REGION, 2017–2027 (USD MILLION) 65

TABLE 45 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 66

TABLE 46 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY REGION, 2017–2027(USD MILLION) 67

TABLE 47 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 67

TABLE 48 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR HIP REPLACEMENT, BY REGION, 2017–2027(USD MILLION) 68

TABLE 49 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR KNEE REPLACEMENT, BY REGION, 2017–2027(USD MILLION) 68

TABLE 50 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR SHOULDER AND ELBOW REPLACEMENT, BY REGION,

2017–2027 (USD MILLION) 69

TABLE 51 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR FRACTURE FIXATION, BY REGION, 2017–2027(USD MILLION) 69

TABLE 52 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR TISSUE FIXATION, BY REGION, 2017–2027(USD MILLION) 70

TABLE 53 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR IMPLANT SURGERY, BY REGION, 2017–2027(USD MILLION) 70

TABLE 54 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR VISCOSUPPLEMENTATION, BY REGION, 2017–2027 (USD MILLION) 71

TABLE 55 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 73

TABLE 56 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR HOSPITALS & CLINICS, BY REGION,2017–2027 (USD MILLION) 73

TABLE 57 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2017–2027 (USD MILLION) 73

TABLE 58 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY REGION, 2017–2027 (USD MILLION) 74

TABLE 59 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET, BY REGION, 2017–2027 (USD MILLION) 76

TABLE 60 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 77

TABLE 61 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS,BY TYPE,

2017–2027 (USD MILLION) 77

TABLE 62 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 77

TABLE 63 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 78

TABLE 64 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 78

TABLE 65 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 78

TABLE 66 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 79

TABLE 67 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 79

TABLE 68 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 79

TABLE 69 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 80

TABLE 70 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 80

TABLE 71 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 81

TABLE 72 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 81

TABLE 73 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 82

TABLE 74 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 82

TABLE 75 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 82

TABLE 76 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 83

TABLE 77 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 83

TABLE 78 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027 (USD MILLION) 84

TABLE 79 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027(USD MILLION) 84

TABLE 80 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027(USD MILLION) 84

TABLE 81 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027(USD MILLION) 85

TABLE 82 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027(USD MILLION) 85

TABLE 83 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027(USD MILLION) 85

TABLE 84 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 86

TABLE 85 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE,2017–2027 (USD MILLION) 86

TABLE 86 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 86

TABLE 87 US: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 87

TABLE 88 US: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE, 2017–2027 (USD MILLION) 87

TABLE 89 US: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 87

TABLE 90 US: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 88

TABLE 91 US: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027 (USD MILLION) 88

TABLE 92 US: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 88

TABLE 93 US: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 89

TABLE 94 US: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 89

TABLE 95 US: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 89

TABLE 96 US: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 90

TABLE 97 US: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 90

TABLE 98 US: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 91

TABLE 99 US: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 91

TABLE 100 CANADA: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 91

TABLE 101 CANADA: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS,BY TYPE,

2017–2027 (USD MILLION) 92

TABLE 102 CANADA: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 92

TABLE 103 CANADA: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 92

TABLE 104 CANADA: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 93

TABLE 105 CANADA: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 93

TABLE 106 CANADA: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 93

TABLE 107 CANADA: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 94

TABLE 108 CANADA: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 94

TABLE 109 CANADA: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 94

TABLE 110 CANADA: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 95

TABLE 111 CANADA: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 95

TABLE 112 CANADA: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 95

TABLE 113 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 96

TABLE 114 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 96

TABLE 115 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 97

TABLE 116 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 97

TABLE 117 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027 (USD MILLION) 98

TABLE 118 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 98

TABLE 119 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 98

TABLE 120 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027(USD MILLION) 99

TABLE 121 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027(USD MILLION) 99

TABLE 122 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027(USD MILLION) 99

TABLE 123 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 100

TABLE 124 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027 (USD MILLION) 100

TABLE 125 LATIN AMERICA: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 100

TABLE 126 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY REGION, 2017–2027 (USD MILLION) 101

TABLE 127 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 102

TABLE 128 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS,BY TYPE,

2017–2027 (USD MILLION) 102

TABLE 129 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 102

TABLE 130 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 103

TABLE 131 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 103

TABLE 132 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 103

TABLE 133 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 104

TABLE 134 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 104

TABLE 135 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 104

TABLE 136 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 105

TABLE 137 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 105

TABLE 138 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 106

TABLE 139 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 106

TABLE 140 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 107

TABLE 141 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 107

TABLE 142 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 108

TABLE 143 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 108

TABLE 144 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 108

TABLE 145 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027 (USD MILLION) 109

TABLE 146 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027(USD MILLION) 109

TABLE 147 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027(USD MILLION) 109

TABLE 148 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027(USD MILLION) 110

TABLE 149 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027(USD MILLION) 110

TABLE 150 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027(USD MILLION) 110

TABLE 151 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 111

TABLE 152 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE,2017–2027 (USD MILLION) 111

TABLE 153 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 111

TABLE 154 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 112

TABLE 155 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS,BY TYPE,

2017–2027 (USD MILLION) 112

TABLE 156 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 113

TABLE 157 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 113

TABLE 158 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 114

TABLE 159 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 114

TABLE 160 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 114

TABLE 161 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 115

TABLE 162 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 115

TABLE 163 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 115

TABLE 164 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 116

TABLE 165 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 116

TABLE 166 GERMANY: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 116

TABLE 167 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 117

TABLE 168 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS,BY TYPE,

2017–2027 (USD MILLION) 117

TABLE 169 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 118

TABLE 170 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 118

TABLE 171 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 119

TABLE 172 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 119

TABLE 173 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 119

TABLE 174 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 120

TABLE 175 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 120

TABLE 176 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 120

TABLE 177 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 121

TABLE 178 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 121

TABLE 179 FRANCE: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 121

TABLE 180 UK: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 122

TABLE 181 UK: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE, 2017–2027 (USD MILLION) 122

TABLE 182 UK: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 122

TABLE 183 UK: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 123

TABLE 184 UK: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027 (USD MILLION) 123

TABLE 185 UK: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 123

TABLE 186 UK: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 124

TABLE 187 UK: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 124

TABLE 188 UK: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 124

TABLE 189 UK: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 125

TABLE 190 UK: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 125

TABLE 191 UK: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 126

TABLE 192 UK: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 126

TABLE 193 ITALY: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 126

TABLE 194 ITALY: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 127

TABLE 195 ITALY: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 127

TABLE 196 ITALY: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 127

TABLE 197 ITALY: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 128

TABLE 198 ITALY: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 128

TABLE 199 ITALY: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 128

TABLE 200 ITALY: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 129

TABLE 201 ITALY: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 129

TABLE 202 ITALY: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 129

TABLE 203 ITALY: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 130

TABLE 204 ITALY: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 130

TABLE 205 ITALY: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 130

TABLE 206 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 131

TABLE 207 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 131

TABLE 208 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 132

TABLE 209 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 132

TABLE 210 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 133

TABLE 211 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 133

TABLE 212 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 133

TABLE 213 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 134

TABLE 214 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 134

TABLE 215 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 134

TABLE 216 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 135

TABLE 217 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 135

TABLE 218 SPAIN: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 135

TABLE 219 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027(USD MILLION) 136

TABLE 220 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 136

TABLE 221 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE,

2017–2027 (USD MILLION) 137

TABLE 222 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE,

2017–2027 (USD MILLION) 137

TABLE 223 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027 (USD MILLION) 138

TABLE 224 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 138

TABLE 225 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 138

TABLE 226 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE,2017–2027 (USD MILLION) 139

TABLE 227 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 139

TABLE 228 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE,2017–2027 (USD MILLION) 139

TABLE 229 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027(USD MILLION) 140

TABLE 230 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE,

2017–2027 (USD MILLION) 140

TABLE 231 REST OF WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027(USD MILLION) 140

TABLE 232 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 141

TABLE 233 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 141

TABLE 234 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 142

TABLE 235 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 142

TABLE 236 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027 (USD MILLION) 143

TABLE 237 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027(USD MILLION) 143

TABLE 238 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027(USD MILLION) 143

TABLE 239 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027(USD MILLION) 144

TABLE 240 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027(USD MILLION) 144

TABLE 241 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027(USD MILLION) 144

TABLE 242 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 145

TABLE 243 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE,2017–2027 (USD MILLION) 145

TABLE 244 EASTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 145

TABLE 245 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 147

TABLE 246 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 147

TABLE 247 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS,BY TYPE,

2017–2027 (USD MILLION) 148

TABLE 248 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 148

TABLE 249 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 148

TABLE 250 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 149

TABLE 251 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 149

TABLE 252 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 149

TABLE 253 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027(USD MILLION) 150

TABLE 254 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 150

TABLE 255 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027(USD MILLION) 150

TABLE 256 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 151

TABLE 257 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027 (USD MILLION) 151

TABLE 258 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 151

TABLE 259 CHINA: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 152

TABLE 260 CHINA: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 152

TABLE 261 CHINA: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 153

TABLE 262 CHINA: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 153

TABLE 263 CHINA: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 154

TABLE 264 CHINA: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 154

TABLE 265 CHINA: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 154

TABLE 266 CHINA: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 155

TABLE 267 CHINA: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 155

TABLE 268 CHINA: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 155

TABLE 269 CHINA: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 156

TABLE 270 CHINA: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 156

TABLE 271 CHINA: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 156

TABLE 272 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 157

TABLE 273 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 157

TABLE 274 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 158

TABLE 275 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 158

TABLE 276 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 159

TABLE 277 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 159

TABLE 278 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 159

TABLE 279 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 160

TABLE 280 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 160

TABLE 281 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 160

TABLE 282 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 161

TABLE 283 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 161

TABLE 284 JAPAN: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 161

TABLE 285 INDIA: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 162

TABLE 286 INDIA: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 162

TABLE 287 INDIA: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 163

TABLE 288 INDIA: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 163

TABLE 289 INDIA: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 164

TABLE 290 INDIA: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 164

TABLE 291 INDIA: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 164

TABLE 292 INDIA: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 165

TABLE 293 INDIA: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 165

TABLE 294 INDIA: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 165

TABLE 295 INDIA: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 166

TABLE 296 INDIA: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 166

TABLE 297 INDIA: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 166

TABLE 298 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 167

TABLE 299 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS,BY TYPE,

2017–2027 (USD MILLION) 167

TABLE 300 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 168

TABLE 301 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 168

TABLE 302 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 169

TABLE 303 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 169

TABLE 304 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 169

TABLE 305 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027(USD MILLION) 170

TABLE 306 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 170

TABLE 307 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 170

TABLE 308 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 171

TABLE 309 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027 (USD MILLION) 171

TABLE 310 AUSTRALIA: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 171

TABLE 311 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 172

TABLE 312 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 172

TABLE 313 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 173

TABLE 314 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027 (USD MILLION) 173

TABLE 315 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 174

TABLE 316 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 174

TABLE 317 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 174

TABLE 318 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027(USD MILLION) 175

TABLE 319 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027(USD MILLION) 175

TABLE 320 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027(USD MILLION) 175

TABLE 321 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 176

TABLE 322 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027 (USD MILLION) 176

TABLE 323 SOUTH KOREA: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 176

TABLE 324 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 177

TABLE 325 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 177

TABLE 326 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE,2017–2027 (USD MILLION) 178

TABLE 327 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE,2017–2027 (USD MILLION) 178

TABLE 328 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE,2017–2027 (USD MILLION) 179

TABLE 329 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027(USD MILLION) 179

TABLE 330 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027(USD MILLION) 179

TABLE 331 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 180

TABLE 332 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027(USD MILLION) 180

TABLE 333 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 180

TABLE 334 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027(USD MILLION) 181

TABLE 335 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027 (USD MILLION) 181

TABLE 336 REST OF ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 181

TABLE 337 MIDDLE EAST& AFRICA: ORTHOPEDIC BIOMATERIALS MARKET, BY REGION, 2017–2027 (USD MILLION) 182

TABLE 338 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 183

TABLE 339 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 183

TABLE 340 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE,2017–2027 (USD MILLION) 183

TABLE 341 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE,2017–2027 (USD MILLION) 184

TABLE 342 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE,2017–2027 (USD MILLION) 184

TABLE 343 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027(USD MILLION) 184

TABLE 344 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027(USD MILLION) 185

TABLE 345 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 185

TABLE 346 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027(USD MILLION) 185

TABLE 347 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 186

TABLE 348 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027(USD MILLION) 186

TABLE 349 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027 (USD MILLION) 187

TABLE 350 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 187

TABLE 351 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 187

TABLE 352 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS,BY TYPE,

2017–2027 (USD MILLION) 188

TABLE 353 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 188

TABLE 354 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 188

TABLE 355 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 189

TABLE 356 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 189

TABLE 357 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 189

TABLE 358 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027(USD MILLION) 190

TABLE 359 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 190

TABLE 360 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027(USD MILLION) 190

TABLE 361 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 191

TABLE 362 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027 (USD MILLION) 191

TABLE 363 MIDDLE EAST: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 191

TABLE 364 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 192

TABLE 365 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY TYPE,

2017–2027 (USD MILLION) 192

TABLE 366 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR SPINAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 193

TABLE 367 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY TYPE, 2017–2027(USD MILLION) 193

TABLE 368 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR ORTHOBIOLOGICS, BY TYPE, 2017–2027(USD MILLION) 194

TABLE 369 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2017–2027 (USD MILLION) 194

TABLE 370 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR METAL, BY TYPE, 2017–2027 (USD MILLION) 194

TABLE 371 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR NON-METAL, BY TYPE, 2017–2027 (USD MILLION) 195

TABLE 372 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR CERAMIC, BY TYPE, 2017–2027 (USD MILLION) 195

TABLE 373 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR POLYMERIC, BY TYPE, 2017–2027 (USD MILLION) 195

TABLE 374 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2017–2027 (USD MILLION) 196

TABLE 375 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET FOR JOINT REPLACEMENT, BY TYPE, 2017–2027(USD MILLION) 196

TABLE 376 AFRICA: ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2017–2027 (USD MILLION) 196

TABLE 377 MAJOR MANUFACTURERS IN THE GLOBAL ORTHOPEDIC BIOMATERIALS MARKET 198

TABLE 378 COMPETITOR DASHBOARD: GLOBAL ORTHOPEDIC BIOMATERIALS MARKET 199

TABLE 379 MOST ACTIVE PLAYER IN THE GLOBAL ORTHOPEDIC BIOMATERIALS MARKET 200

TABLE 380 PRODUCT LAUNCHES/PRODUCT APPROVALS 201

TABLE 381 ACQUISITIONS 202

TABLE 382 COLLABORATIONS/JOINT VENTURES 203

TABLE 383 EXPANSIONS 203

TABLE 384 STRYKER: PRODUCTS/SERVICES OFFERED 205

TABLE 385 STRYKER: KEY DEVELOPMENTS 206

TABLE 386 COORSTEK INC.: PRODUCTS/SERVICES OFFERED 208

TABLE 387 COORSTEK INC.: KEY DEVELOPMENTS 209

TABLE 388 ZIMMER BIOMET HOLDINGS INC.: PRODUCTS/SERVICES OFFERED 211

TABLE 389 ZIMMER BIOMET HOLDINGS INC.: KEY DEVELOPMENTS 212

TABLE 390 INSTITUT STRAUMANN AG: PRODUCTS/SERVICES OFFERED 215

TABLE 391 INSTITUT STRAUMANN AG: KEY DEVELOPMENTS 215

TABLE 392 KYOCERA CORPORATION: PRODUCTS/SERVICES OFFERED 218

TABLE 393 KYOCERA CORPORATION: KEY DEVELOPMENTS 218

TABLE 394 SMITH+ NEPHEW: PRODUCTS/SERVICES OFFERED 221

TABLE 395 SMITH+ NEPHEW: KEY DEVELOPMENTS 221

TABLE 396 3M: PRODUCTS/SERVICES OFFERED 225

TABLE 397 3M: KEY DEVELOPMENTS 225

TABLE 398 NOBEL BIOCARE HOLDING AG: PRODUCTS/SERVICES OFFERED 229

TABLE 399 NOBEL BIOCARE HOLDING AG: KEY DEVELOPMENTS 229

TABLE 400 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED 232

TABLE 401 DEPUY SYNTHES: PRODUCTS/SERVICES OFFERED 236

TABLE 402 DEPUY SYNTHES: KEY DEVELOPMENTS 236


LIST OF FIGURES

FIGURE 1 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET STRUCTURE 28

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 34

FIGURE 3 DYNAMICS: ORTHOPEDIC BIOMATERIALS MARKET 37

FIGURE 4 DRIVERS: IMPACT ANALYSIS 39

FIGURE 5 RESTRAINT: IMPACT ANALYSIS 40

FIGURE 6 VALUE CHAIN ANALYSIS: ORTHOPEDIC BIOMATERIALS MARKET 41

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: ORTHOPEDIC BIOMATERIALS MARKET 43

FIGURE 8 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY PRODUCT, 2019 & 2027 (USD MILLION) 47

FIGURE 9 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY RECONSTRUCTIVE JOINT REPLACEMENTS,2019 & 2027 (USD MILLION) 48

FIGURE 10 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY SPINAL IMPLANTS, 2019 & 2027 (USD MILLION) 51

FIGURE 11 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY DENTAL IMPLANTS, 2019 & 2027 (USD MILLION) 54

FIGURE 12 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY ORTHOBIOLOGICS, 2019 & 2027 (USD MILLION) 57

FIGURE 13 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY MATERIAL CLASS, 2019 & 2027 (USD MILLION) 61

FIGURE 14 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY METAL, 2019 & 2027 (USD MILLION) 62

FIGURE 15 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY NON-METAL, 2019 & 2027 (USD MILLION) 65

FIGURE 16 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2019 & 2027 (USD MILLION) 70

FIGURE 17 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY END USER, 2019 & 2027 (USD MILLION) 76

FIGURE 18 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET, BY REGION, 2019 & 2027 (USD MILLION) 78

FIGURE 19 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY REGION, 2019 (%) 79

FIGURE 20 AMERICAS: ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY REGION, 2019 (%) 80

FIGURE 21 NORTH AMERICA: ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY COUNTRY, 2019 (%) 88

FIGURE 22 EUROPE: ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY REGION 2019 (%) 116

FIGURE 23 WESTERN EUROPE: ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY COUNTRY, 2019 (%) 124

FIGURE 24 ASIA-PACIFIC: ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY COUNTRY, 2019 (%) 181

FIGURE 25 MIDDLE EAST & AFRICA: ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY REGION, 2019 (%) 231

FIGURE 26 BENCHMARKING OF MAJOR COMPETITORS 254

FIGURE 27 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ORTHOPEDIC BIOMATERIALS MARKET 255

FIGURE 28 GLOBAL ORTHOPEDIC BIOMATERIALS MARKET: COMPETITIVE LANDSCAPE 256

FIGURE 29 STRYKER: FINANCIAL OVERVIEW SNAPSHOT 261

FIGURE 30 STRYKER: SWOT ANALYSIS 263

FIGURE 31 COORSTEK INC.: SWOT ANALYSIS 265

FIGURE 32 ZIMMER BIOMET HOLDINGS INC.: FINANCIAL OVERVIEW SNAPSHOT 266

FIGURE 33 ZIMMER BIOMET HOLDINGS INC.: SWOT ANALYSIS 269

FIGURE 34 INSTITUT STRAUMANN AG: FINANCIAL OVERVIEW SNAPSHOT 270

FIGURE 35 INSTITUT STRAUMANN AG: SWOT ANALYSIS 272

FIGURE 36 KYOCERA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 273

FIGURE 37 KYOCERA CORPORATION: SWOT ANALYSIS 274

FIGURE 38 SMITH+ NEPHEW: FINANCIAL OVERVIEW SNAPSHOT 276

FIGURE 39 SMITH+ NEPHEW: SWOT ANALYSIS 278

FIGURE 40 3M: FINANCIAL OVERVIEW SNAPSHOT 280

FIGURE 41 3M: SWOT ANALYSIS 282

FIGURE 42 NOBEL BIOCARE HOLDING AG: FINANCIAL OVERVIEW SNAPSHOT 284

FIGURE 43 NOBEL BIOCARE HOLDING AG: SWOT ANALYSIS 286

FIGURE 44 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT 287

FIGURE 45 MEDTRONIC PLC: SWOT ANALYSIS 289

FIGURE 46 DEPUY SYNTHES: FINANCIAL OVERVIEW SNAPSHOT 291

FIGURE 47 DEPUY SYNTHES: SWOT ANALYSIS 293



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.